Novel UV-induced melanoma mouse model dependent on Endothelin3 signaling

Pigment Cell and Melanoma Research

Volumn 27, Issue 5, 2014, Pages 839-842

  Benaduce, Ana Paula ^a   Batista, Deannys ^a   Grilo, Gabriel ^a   Jorge, Karen ^a   Cardero, Diana ^a   Milikowski, Clara ^b   Kos, Lidia ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 3; MELANIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; BLUE NEVUS; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; HISTOPATHOLOGY; HYPERPIGMENTATION; LETTER; MELANOCYTE; MELANOGENESIS; MELANOMA; MOUSE; NEWBORN; NONHUMAN; RADIATION EXPOSURE; RADIATION INDUCED NEOPLASM; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; SURVIVAL TIME; TUMOR MICROENVIRONMENT; ULTRAVIOLET RADIATION; ANIMAL; CYTOLOGY; DISEASE MODEL; FLUORESCENCE MICROSCOPY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; LIGHT; LYMPH NODE METASTASIS; METABOLISM; MUTATION; PATHOLOGY; SKIN NEOPLASMS; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; ENDOTHELIN-3; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; LIGHT; LYMPHATIC METASTASIS; MELANOCYTES; MELANOMA; MICE; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; MUTATION; NEOPLASMS, RADIATION-INDUCED; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 84907998401     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12281     Document Type: Letter

References (12)

1. Bagnato, A., Rosano, L., Spinella, F., Di Castro, V., Tecce, R., and Natali, P.G. (2004). Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progression. Cancer Res. 64, 1436-1443.
2. Garcia, R.J., Ittah, A., Mirabal, S., Figueroa, J., Lopez, L., Glick, A.B., and Kos, L. (2008). Endothelin 3 induces skin pigmentation in a keratin-driven inducible mouse model. J. Invest. Dermatol. 128, 131-142.
3. Grichnik, J.M. (2008). Melanoma, nevogenesis, and stem cell biology. J. Invest. Dermatol. 128, 2365-2380.
4. Kannan, K., Sharpless, N.E., Xu, J., O'Hagan, R.C., Bosenberg, M., and Chin, L. (2003). Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model. Proc. Natl Acad. Sci. USA 100, 1221-1225.
5. Kraemer, K.H., Lee, M.M., Andrews, A.D., and Lambert, W.C. (1994). The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch. Dermatol. 130, 1018-1021.
6. Nakane, H., Takeuchi, S., Yuba, S. et al. (1995). High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene. Nature 377, 165-168.
7. Noonan, F.P., Recio, J.A., Takayama, H., Duray, P., Anver, M.R., Rush, W.L., De Fabo, E.C., and Merlino, G. (2001). Neonatal sunburn and melanoma in mice. Nature 413, 271-272.
8. Noonan, F.P., Zaidi, M.R., Wolnicka-Glubisz, A. et al. (2012). Melanoma induction by ultraviolet A but not ultraviolet B radiation requires melanin pigment. Nat. Commun. 3, 884.
9. Queille, S., Drougard, C., Sarasin, A., and Daya-Grosjean, L. (2001). Effects of XPD mutations on ultraviolet-induced apoptosis in relation to skin cancer-proneness in repair-deficient syndromes. J. Invest. Dermatol. 117, 1162-1170.
10. Van Schanke, A., Van Venrooij, G.M., Jongsma, M.J., Banus, H.A., Mullenders, L.H., Van Kranen, H.J., and De Gruijl, F.R. (2006). Induction of nevi and skin tumors in Ink4a/Arf Xpa knockout mice by neonatal, intermittent, or chronic UVB exposures. Cancer Res. 66, 2608-2615.
11. Wood, S.R., Berwick, M., Ley, R.D., Walter, R.B., Setlow, R.B., and Timmins, G.S. (2006). UV causation of melanoma in Xiphophorus is dominated by melanin photosensitized oxidant production. Proc. Natl Acad. Sci. USA 103, 4111-4115.
12. Yamazaki, F., Okamoto, H., Matsumura, Y., Tanaka, K., Kunisada, T., and Horio, T. (2005). Development of a new mouse model (xeroderma pigmentosum a-deficient, stem cell factor-transgenic) of ultraviolet B-induced melanoma. J. Invest. Dermatol. 125, 521-525.